Claes Mörlin

3.6k total citations · 1 hit paper
37 papers, 2.6k citations indexed

About

Claes Mörlin is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Claes Mörlin has authored 37 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Claes Mörlin's work include Blood Pressure and Hypertension Studies (12 papers), Renal and Vascular Pathologies (11 papers) and Hormonal Regulation and Hypertension (8 papers). Claes Mörlin is often cited by papers focused on Blood Pressure and Hypertension Studies (12 papers), Renal and Vascular Pathologies (11 papers) and Hormonal Regulation and Hypertension (8 papers). Claes Mörlin collaborates with scholars based in Sweden, Finland and United Kingdom. Claes Mörlin's co-authors include K Luomanmäki, Jan Lanke, Leo Niskanen, Lennart Hansson, Bengt E. Karlberg, Thomas Hedner, Anders Niklason, Ulf dé Fairé, Lars Lindholm and Björn Dahlöf and has published in prestigious journals such as The Lancet, PLoS ONE and The Journal of Urology.

In The Last Decade

Claes Mörlin

35 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1999 1.5k citations Lennart Hansson, Lars Lindholm et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claes Mörlin Sweden	12	1.7k	930	616	321	281	37	2.6k
Torben Haghfelt Denmark	28	2.2k 1.3×	527 0.6×	467 0.8×	232 0.7×	468 1.7×	115	4.4k
Daniel E. Hilleman United States	31	1.1k 0.6×	434 0.5×	124 0.2×	116 0.4×	186 0.7×	147	3.3k
Raymond O. Estacio United States	27	2.3k 1.4×	1.4k 1.5×	107 0.2×	347 1.1×	181 0.6×	57	3.9k
Steffan Ekman Switzerland	11	2.6k 1.6×	1.2k 1.3×	92 0.1×	301 0.9×	157 0.6×	15	3.1k
Jean‐Pierre Boissel France	22	1.7k 1.0×	458 0.5×	71 0.1×	96 0.3×	168 0.6×	53	2.9k
GD Johnston United Kingdom	25	1.8k 1.1×	603 0.6×	170 0.3×	323 1.0×	145 0.5×	72	3.1k
John B. Kostis United States	21	1.8k 1.1×	558 0.6×	115 0.2×	151 0.5×	102 0.4×	55	2.3k
Pieter A. de Graeff Netherlands	24	1.3k 0.8×	350 0.4×	125 0.2×	96 0.3×	214 0.8×	63	2.1k
Tina Ken Schramm Denmark	16	1.5k 0.9×	613 0.7×	80 0.1×	550 1.7×	97 0.3×	24	2.8k
Marion R. Wofford United States	22	1.3k 0.8×	858 0.9×	155 0.3×	274 0.9×	49 0.2×	37	3.3k

Countries citing papers authored by Claes Mörlin

Since Specialization

Citations

This map shows the geographic impact of Claes Mörlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claes Mörlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claes Mörlin more than expected).

Fields of papers citing papers by Claes Mörlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claes Mörlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claes Mörlin. The network helps show where Claes Mörlin may publish in the future.

Co-authorship network of co-authors of Claes Mörlin

This figure shows the co-authorship network connecting the top 25 collaborators of Claes Mörlin. A scholar is included among the top collaborators of Claes Mörlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claes Mörlin. Claes Mörlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gillespie, Ulrika, Anna Alassaad, Margareta Hammarlund‐Udenaes, et al.. (2013). Effects of Pharmacists' Interventions on Appropriateness of Prescribing and Evaluation of the Instruments' (MAI, STOPP and STARTs') Ability to Predict Hospitalization–Analyses from a Randomized Controlled Trial. PLoS ONE. 8(5). e62401–e62401. 96 indexed citations

Tully, Mary P., et al.. (2013). Transfer of data or re-creation of knowledge – Experiences of a shared electronic patient medical records system. Research in Social and Administrative Pharmacy. 9(6). 965–974. 10 indexed citations

Gillespie, Ulrika, Claes Mörlin, Margareta Hammarlund‐Udenaes, & Mariann Hedström. (2012). Perceived value of ward-based pharmacists from the perspective of physicians and nurses. International Journal of Clinical Pharmacy. 34(1). 127–135. 47 indexed citations

Hansson, Lennart, Lars Lindholm, Leo Niskanen, et al.. (1999). Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. The Lancet. 353(9153). 611–616. 1480 indexed citations breakdown →

Hansson, Lennart, Thomas Hedner, Lars Lindholm, et al.. (1997). The Captopril Prevention Project (CAPPP) in Hypertension—Baseline Data and Current Status. Blood Pressure. 6(6). 365–367. 25 indexed citations

Ström, Kerstin, et al.. (1995). Effect of protriptyline, 10 mg daily, on chronic hypoxaemia in chronic obstructive pulmonary disease. European Respiratory Journal. 8(3). 425–429. 18 indexed citations

Åberg, H, Claes Mörlin, & Hans Lithell. (1995). Different long-term metabolic effects of enalapril and atenolol in patients with mild hypertension. EGTA Group.. PubMed. 9(2). 149–53. 11 indexed citations

Lind, Lars, et al.. (1994). Electrocardiographic changes during antihypertensive treatment with diltiazem in relation to the achieved serum levels of the drug. Scandinavian Journal of Clinical and Laboratory Investigation. 54(4). 337–340. 2 indexed citations

Jounela, A. J., et al.. (1994). Relation Between Low Dose of Hydrochlorothiazide, Antihypertensive Effect and Adverse Effects. Blood Pressure. 3(4). 231–235. 29 indexed citations

10.

Pollare, Thomas, et al.. (1989). Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. Journal of Hypertension. 7(7). 551–559. 158 indexed citations

11.

Hvarfner, Andreas, Reinhold Bergström, Hans Lithell, et al.. (1988). Changes in calcium metabolic indices during long-term treatment of patients with essential hypertension. Clinical Science. 75(5). 543–549. 9 indexed citations

12.

Hvarfner, Andreas, R. Bergström, Claes Mörlin, Elvar Theodorsson, & Sverker Ljunghall. (1988). The calcitonin gene‐related peptide (CGRP) response to intravenous calcium is related to blood pressure. Acta Physiologica Scandinavica. 132(3). 439–440. 9 indexed citations

13.

Wallin, B. Gunnar, Claes Mörlin, & Paul Hjemdahl. (1987). Muscle sympathetic activity and venous plasma noradrenaline concentrations during static exercise in normotensive and hypertensive subjects. Acta Physiologica Scandinavica. 129(4). 489–497. 65 indexed citations

14.

Hägg, Anders, H Åberg, I Eriksson, L.‐E. Lörelius, & Claes Mörlin. (1987). Fibromuscular dysplasia of the renal artery--management and outcome.. PubMed. 153(1). 15–20. 10 indexed citations

15.

Hägg, Anders, Lars‐Erik Lörelius, Claes Mörlin, & Hans Åberg. (1985). Percutaneous Transluminal Renal Artery Dilatation for Fibromuscular Dysplasia with Special Reference to the Acute Effects on the Renin-Angiotensin-Aldosterone System and Blood Pressure. Scandinavian Journal of Urology and Nephrology. 19(3). 205–209. 2 indexed citations

16.

Lörelius, L.‐E., A. Hemmingsson, Anders Hägg, Claes Mörlin, & H Åberg. (1985). Progressive Fibromusclular Dysplasia of the Renal Artery. Acta Radiologica Diagnosis. 26(6). 705–708. 7 indexed citations

17.

Mörlin, Claes, et al.. (1983). Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man. Acta Physiologica Scandinavica. 119(2). 117–121. 72 indexed citations

18.

Lörelius, L.‐E., Claes Mörlin, L Wide, Lars Wiklund, & H Åberg. (1979). The effect of splanchnic block on renin production and renal haemodynamics in hypertensive patients. Scandinavian Journal of Clinical and Laboratory Investigation. 39(3). 241–246. 2 indexed citations

19.

Mörlin, Claes, et al.. (1979). THE EFFECT OF SPLANCHNIC BLOCK ON RENAL HAEMODYNAMICS AND RENIN PRODUCTION IN HYPERTENSIVE PATIENTS. Acta Medica Scandinavica. 205(S625). 122–126. 2 indexed citations

20.

Lörelius, L.‐E., et al.. (1978). Renal haemodynamics before and after splanchnic block in patients with hypertension. Scandinavian Journal of Clinical and Laboratory Investigation. 38(3). 233–240. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact